ReviewPharmaceutics2022

Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue.

Roxana-Maria Amarandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.